Regulating Dangerous Research

The US government has come out with new rules for life science research deemed risky.

Written byKate Yandell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

CDC, GREG KNOBLOCHThe US government earlier this week (February 21) released two documents outlining new policies for researchers dealing with certain pathogens and toxins, including H5N1 avian influenza, ScienceInsider reported.

The new policies have been released in the wake a controversy over bird flu research that began in 2011 after scientists announced that they had made a virus in the lab that could pass between mammals. Researchers on the bird flu virus, H5N1, voluntarily halted their work until last month to give the community time to come up with rules for conducting the research safely.

One of the documents comes from Health and Human Services (HHS) and deals directly with what types of H5N1 research the agency will fund. Top officials from the HHS and the National Institutes of Health described the new criteria, which are based partly on a meeting held in December by the HHS, yesterday (February 22) in Science.

According to the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery